SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

NORML

MARCH 7, 2019

Introduced was The Ending Federal Marijuana Prohibition Act of 2019, to remove marijuana from the federal Controlled Substances list and allow states the freedom to regulate marijuana as they choose, without federal interference. “The Ending Federal Prohibition Act is about acknowledging political, scientific, and economic reality. .”

Legislation 251

Legislation Marijuana Policy Research and Development 251

Veriheal

MARCH 20, 2024

A federally funded study on the effects of adult-use legalization looked at data on middle schoolers in New Mexico and Nevada between 2017 and 2019. During this period, recreational cannabis was legal in Nevada, and medicinal cannabis was legal in New Mexico. percent in 2019. percent in 2017 to 13.3 percent to 8.9

Legalization 104

Legalization Consumption Cannabis Marijuana 104

Cannabis Law Report

FEBRUARY 2, 2022

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern. “We

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

NORML

JANUARY 24, 2019

179 : The VA Medicinal Cannabis Research Act of 2019 to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans. Representatives Lou Correa (D-CA) and Clay Higgins (R-LA) and Senators Jon Tester (D-MT) and Dan Sullivan (R-AK) have introduced legislation, HR 712 / S.

Legislation 228

Legislation Chronic Pain Safety Medicine 228

Cannabis Law Report

DECEMBER 19, 2021

17 December 2021: New medicinal cannabis products have been verified as meeting the minimum quality standard – Read more. obtained consent for distribution under the Medicines Act 1981 (approved and provisionally approved medicines). Prescription medicine. Prescription Medicine. Prescription Medicine.

Medicine 52

Medicine Pharmaceutical THC Sativa 52

Cannabis Law Report

DECEMBER 2, 2021

Generally, medicinal cannabis products are only available, on prescription, if they have: been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or. Prescription Medicine. Prescription Medicine. 4 Oct 2021.

Medicine 52

Medicine Pharmaceutical Sativa THC 52

Cannabis Law Report

DECEMBER 4, 2019

In this article, Dr. Snyder distills her analysis of hemp testing during the 2018 and 2019 growing seasons. Based on her data, Dr. Snyder finds that requiring “Total THC” concentrations not to exceed 0.3%, rather than just limiting ?9-THC, This data shows that 97.4% (370 out of 380) samples fell at or below the 0.3% limit for ?9-THC

Data 59

Data THC Strains Concentrates 59

Sensi Seeds

DECEMBER 10, 2018

In 2019 the first official WHO evaluation of the therapeutic value of the cannabis plant in more than 80 years will be released. They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients.

Medicine 81

Medicine Research and Development Data Policy 81

NORML

JANUARY 28, 2019

It’s understandable lawmakers want reliable data before making a decision. The good news for Kentucky legislators is the data already i s available. National Library of Medicine has more than 26,000 published studies/reviews across 24 databases regarding cannabis available to read online. 8 – state Rep.

Data 187

Data Clinical Trials Chronic Pain Medicine 187

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Furthermore, Nugg MD’s data shows just how vital MMJ access has become in modern society’s health landscape.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

AUGUST 26, 2021

The $817 million total for 2020-21 is 55 percent higher than the total for 2019-20. Annual Report on Tax Exemptions for Medicinal Cannabis [Publication Details]. Annual Report on Tax Exemptions for Medicinal Cannabis. Chapter 837 o f 2019 (S B 34 , Wiener) established new tax exemptions for donations of medicinal cannabis.

Marijuana 105

Marijuana Medicine Retail Cultivation 105

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

DECEMBER 8, 2019

Editor’s note: The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data. On the one hand, cannabinoids produced by cannabis clearly have medicinal benefits.3-5

Medicine 59

Medicine Research and Development Food Cannabinoids 59

Cannabis Law Report

JULY 13, 2021

As the psychedelic renaissance contributes to a swelling pool of safety and efficacy data pertaining to the potential therapeutic benefits of psychedelic medicine, many localities—particularly in North America—are revising their legal frameworks. This is what they are saying. Mapping Psychedelic Drug Policy Reform. A number of U.S.

Decriminalization 105

Decriminalization Legalization Data Safety 105

Cannabis Law Report

NOVEMBER 10, 2019

Exclusive data collaboration between The Green Fund and Freshleaf Analytics. In April 2019, QLD amended their patient access process making it easier for doctors to write prescriptions. Record growth continues. It’s worth remembering how far the Australian market has come in just the last 12 months.

Access 45

Access Medicine Data Patients 45

Cannabis Info

JULY 12, 2019

CBD for Pets Yes the Data says it works ! When your pet gets sick, you give up everything and try to find them the best possible medicine or treatment available. Lets review some data. Perhaps one of the best-known medicinal uses for CBD is its ability to help controls seizures, tremors, tics, and spasms.

Pets 45

Pets Data CBD Cannabinoids 45

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

JULY 19, 2021

Since its move from the illicit market, to the legalization of medicinal cannabis in 1996, and continued positive shifts of perceptions of cannabis, there has been exponential growth in the industry. In 2019, medicinal cannabis taxation brought in over $1M to the city of Vista.

Medicine 105

Medicine Programs Data Events 105

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

Cannabis Law Report

JUNE 11, 2019

This report provides an analysis of the latest data on the drug situation and responses to it across the European Union, Norway and Turkey. It is supported by other, online information resources, including our Statistical Bulletin, containing source data. This is a complex area.

Medicine 40

Medicine Data THC Policy 40

Veriheal

JANUARY 7, 2022

After the 2019 vape crisis that resulted in at least 68 deaths across the U.S., Based on the study’s data, the use of cannabis among 12th graders over the last several years has consistently remained around the 35% mark. Cannabis is a natural medicine that is legal in over half of the U.S. and Canada. for medical purposes.

Vaping 98

Vaping Education Data Consumption 98

NORML

FEBRUARY 28, 2019

Today, Senator Cory Booker (D-NJ) along with Representatives Barbara Lee (D-CA) and Ro Khanna (D-CA), introduced The Marijuana Justice Act of 2019, to remove marijuana from the Controlled Substances Act and incentivize states to end the racially disparate criminalization of marijuana consumers.

Marijuana 279

Marijuana Policy Legislation Research and Development 279

MassRoots

MARCH 8, 2019

Women who consume cannabis before sex have better orgasms than those who do not, according to new data. Excited to see my published paper in Sexual Medicine! beckyklynn) March 4, 2019. Published online March 1, 2019 in Sexual Medicine , the data was analyzed and interpreted by: Becky K. Lynn, MD Julia D.

Data 112

Data Chronic Pain Medicine Patients 112

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. The use of cannabis as a therapeutic and medicinal aid is widely supported.

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

JUNE 23, 2021

In 2019, the island’s economy grew by 2.1% By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 in real terms to £4.97 to reach 3.2 billion euros ($3.75

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JULY 8, 2021

One of the major concerns raised in this commentary is that both medicinal use of tried cigarettes and recreational marijuana of cannabis are being promoted in a way that avoids the FDA’s normal testing and regulatory processes, which are otherwise needed for all drugs advertised for human use in the United States. percent or 16.7

Legalization 98

Legalization Advocacy Legislation Cannabis 98

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. I know how to analyze data.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

NOVEMBER 20, 2019

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data. The data – which covers November 2018 through August 2019 – relates only to prescriptions in England.

Clinical Trials 45

Clinical Trials Data Medicine Patients 45

Cannabis Law Report

NOVEMBER 22, 2019

The Illinois Department of Agriculture is hosting a hemp summit next month to discuss the 2019 growing season, best practices, lessons learned and the future of the hemp industry in Illinois. Petitioners argue that the government, when enacting the NDPS Act, failed to consider the potential medicinal benefits of the drug.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

Veriheal

MAY 18, 2023

The team peered into the findings of numerous articles published between 2001 and 2019. Once they felt satisfied with their takeaways, they put together specific guidelines featuring data from 70 studies, 51 of which were original studies and 19 of which were systematic reviews. used it in the last month.

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

The Cannigma

FEBRUARY 2, 2021

As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis. Still, research is ongoing.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Medicinal Genomics

MARCH 27, 2019

Editor’s Note: This following blog is an excerpt from an article that appeared in the March/April 2019 issue of Terpenes & Testing Magazine. Whole Genome Data. When it comes to sequencing your cultivar’s genetics for IP purposes, the more data the better. View the full article. . Publish to the Blockchain.

Data 94

Data Strains Terpenes Cultivation 94

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. In addition, Colorado’s 2019 rate of 35.9%

Business 52

Business Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. In addition, Colorado’s 2019 rate of 35.9%

Retail 52

Retail Data Safety Cannabinoids 52